COMMENTARY:A Hammer in Search
of a Nail
DEA grows impatient with the pace at which the FDA addresses opioid abuse.
When some pharmacists refused to dispense Plan B, the so-called “morning after pill,” because of their personal moral beliefs, reproductive rights advocates and the media swooped down with all guns ablaze. “Denying access!” they cried. “Abusing their state licenses!” shouted others. Read More